Inflammatory markers response to citrulline supplementation in patients with non-alcoholic fatty liver disease: a randomized, double blind, placebo-controlled, clinical trial

被引：0
|
作者：
Zahra Darabi
Mina Darand
Zahra Yari
Mehdi Hedayati
Amirhosein Faghihi
Shahram Agah
Azita Hekmatdoost
机构：
[1] Shahid Beheshti University of Medical Sciences,Department of Clinical Nutrition and Dietetics, Faculty of Nutrition Sciences and Food Technology, National Nutrition and Food Technology Research Institute
[2] Shahid Beheshti University of Medical Sciences,Cellular and Molecular Endocrine Research Center, Research Institute for Endocrine Sciences
[3] Iran University of Medical Sciences,Colorectal Research Center
来源：
BMC Research Notes | / 12卷
关键词：
Citrulline; NAFLD; Fatty liver; Inflammation; NASH;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Lubiprostone in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled, phase 2a trial
    Kessoku, Takaomi
    Imajo, Kento
    Kobayashi, Takashi
    Ozaki, Anna
    Iwaki, Michihiro
    Honda, Yasushi
    Kato, Takayuki
    Ogawa, Yuji
    Tomeno, Wataru
    Kato, Shingo
    Higurashi, Takuma
    Yoneda, Masato
    Kirikoshi, Hiroyuki
    Kubota, Kazumi
    Taguri, Masataka
    Yamanaka, Takeharu
    Usuda, Haruki
    Wada, Koichiro
    Kobayashi, Noritoshi
    Saito, Satoru
    Nakajima, Atsushi
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2020, 5 (11): : 996 - 1007
  • [32] Curcumin and inflammation in non-alcoholic fatty liver disease: a randomized, placebo controlled clinical trial
    Saeede Saadati
    Amir Sadeghi
    Asieh Mansour
    Zahra Yari
    Hossein Poustchi
    Mehdi Hedayati
    Behzad Hatami
    Azita Hekmatdoost
    BMC Gastroenterology, 19
  • [33] Flaxseed powder supplementation in non-alcoholic fatty liver disease: a randomized controlled clinical trial
    Tian, Yanyan
    Zhou, Yuhao
    Liao, Wang
    Xia, Jiayue
    Hu, Qiaosheng
    Zhao, Qing
    Zhang, Rui
    Sun, Guiju
    Yang, Ligang
    Li, Lihua
    FOOD & FUNCTION, 2025, 16 (04) : 1389 - 1406
  • [34] A randomized controlled trial of kalmegh supplementation on non-alcoholic fatty liver disease
    Nandekar, Sanket
    Kumar, Sunil
    Yadav, Devesh
    Sen, Binay
    Gadge, Pournima
    JOURNAL OF HEPATOLOGY, 2023, 78 : S830 - S830
  • [35] Green Tea in Non-Alcoholic Fatty Liver Disease: A Double Blind Randomized Clinical Trial
    Tabatabaee, Seyed Mohammad
    Alavian, Seyed Moayed
    Ghalichi, Leila
    Miryounesi, Seyed Mohammad
    Mousavizadeh, Kazem
    Jazayeri, Shima
    Vafa, Mohammad Reza
    HEPATITIS MONTHLY, 2017, 17 (12)
  • [36] Vitamin D for treatment of non-alcoholic fatty liver disease detected by transient elastography: A randomized, double-blind, placebo-controlled trial
    Lukenda Zanko, Vesna
    Domislovic, Viktor
    Trkulja, Vladimir
    Krznaric-Zrnic, Irena
    Turk-Wensveen, Tamara
    Krznaric, Zeljko
    Filipec Kanizaj, Tajana
    Radic-Kristo, Delfa
    Bilic-Zulle, Lidija
    Orlic, Lidija
    Dinjar-Kujundzic, Petra
    Poropat, Goran
    Stimac, Davor
    Hauser, Goran
    Mikolasevic, Ivana
    DIABETES OBESITY & METABOLISM, 2020, 22 (11): : 2097 - 2106
  • [37] The effect of soy isoflavones supplementation on metabolic status in patients with non-alcoholic fatty liver disease: a randomized placebo controlled clinical trial
    Tehrani, Asal Neshatbini
    Hatami, Behzad
    Daftari, Ghazal
    Hekmatdoost, Azita
    Yari, Zahra
    Salehpour, Amin
    Hosseini, Seyed Ahmad
    Helli, Bizhan
    BMC PUBLIC HEALTH, 2024, 24 (01)
  • [38] Effects of Phytosterols Supplementation on Serum Levels of Lipid Profile, Liver Enzymes, Inflammatory Markers, Adiponectin and Leptin in Patients Affected by Non-Alcoholic Fatty Liver Disease: A Double Blind, Placebo-Controlled, Randomized Clinical Trial (vol 37, pg 653, 2018)
    Shahi, Majid Mohammad
    Javanmardi, Mohammad Ali
    Seyedian, Seyed Saeed
    Haghighizadeh, Mohammad Hossein
    JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION, 2019, 38 (04) : 386 - 386
  • [39] The effect of melatonin on treatment of patients with non-alcoholic fatty liver disease: a randomized double blind clinical trial
    Bahrami, Mina
    Cheraghpour, Makan
    Jafarirad, Sima
    Alavinejad, Pejman
    Asadi, Fariba
    Hekmatdoost, Azita
    Mohammadi, Mahsa
    Yari, Zahra
    COMPLEMENTARY THERAPIES IN MEDICINE, 2020, 52
  • [40] Green cardamom supplementation improves serum irisin, glucose indices, and lipid profiles in overweight or obese non-alcoholic fatty liver disease patients: a double-blind randomized placebo-controlled clinical trial
    Daneshi-Maskooni, Milad
    Keshavarz, Seyed Ali
    Qorbani, Mostafa
    Mansouri, Siavash
    Alavian, Seyed Moayed
    Badri-Fariman, Mahtab
    Jazayeri-Tehrani, Seyed Ali
    Sotoudeh, Gity
    BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2019, 19 (1):
12345